- Home
- GDYN vs VIR Comparison
GDYN vs VIR Comparison
Compare GDYN & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDYN
- VIR
- Stock Information
- Founded
- GDYN 2006
- VIR 2016
- Country
- GDYN United States
- VIR United States
- Employees
- GDYN N/A
- VIR N/A
- Industry
- GDYN Computer Software: Prepackaged Software
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- GDYN Technology
- VIR Health Care
- Exchange
- GDYN Nasdaq
- VIR Nasdaq
- Market Cap
- GDYN 652.8M
- VIR 706.4M
- IPO Year
- GDYN N/A
- VIR 2019
- Fundamental
- Price
- GDYN $8.33
- VIR $6.07
- Analyst Decision
- GDYN Strong Buy
- VIR Strong Buy
- Analyst Count
- GDYN 5
- VIR 11
- Target Price
- GDYN $14.80
- VIR $25.73
- AVG Volume (30 Days)
- GDYN 1.3M
- VIR 1.4M
- Earning Date
- GDYN 10-30-2025
- VIR 10-30-2025
- Dividend Yield
- GDYN N/A
- VIR N/A
- EPS Growth
- GDYN N/A
- VIR N/A
- EPS
- GDYN 0.19
- VIR N/A
- Revenue
- GDYN $389,227,000.00
- VIR $19,000,000.00
- Revenue This Year
- GDYN $20.78
- VIR N/A
- Revenue Next Year
- GDYN $10.71
- VIR $15.25
- P/E Ratio
- GDYN $42.93
- VIR N/A
- Revenue Growth
- GDYN 22.27
- VIR N/A
- 52 Week Low
- GDYN $7.37
- VIR $4.16
- 52 Week High
- GDYN $25.50
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- GDYN 52.29
- VIR 67.25
- Support Level
- GDYN $7.98
- VIR $5.52
- Resistance Level
- GDYN $8.64
- VIR $6.00
- Average True Range (ATR)
- GDYN 0.37
- VIR 0.33
- MACD
- GDYN 0.09
- VIR 0.06
- Stochastic Oscillator
- GDYN 67.90
- VIR 76.05
About GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.